Abstract
The spine is the most common skeletal site for metastatic disease and up to 10% of all patients with cancer develop spinal metastases during the course of their disease (Kakhki et al., Nucl Med Rev Cent East Eur 16(2):66–69, 2013; Zacharia et al., Indian J Surg Oncol 9(1):46–51, 2018; Laufer et al., Cancer Control 19(2):122–128, 2012). Most tumors spread to the spine via hematogenous venous circulation; however, local invasion from close proximity tumors is also observed. In concordance with relative bone mass, the thoracic spine is the most common site for spread, followed by the lumbosacral and cervical spine, respectively. With the aging population and robust development of systemic treatment options for various cancers, the prevalence of spine metastases is likely to increase over the coming years. While the vast majority are confined to the bony elements of the spine, those with epidural extension or intradural location often require treatment to preserve neurologic status and quality of life. As with systemic treatment options, various advances in multi-modality of treatment of these tumors have accelerated over the past 20 years and resulted in excellent local control rates for the majority of patients. Nonetheless, there continues to be a void in our understanding of genetic tropism for certain primary tumors to metastasize to the spine and what mutations portend a more favorable prognosis based on available treatment options, which is an active area of research. Currently, the focus of management involves timely diagnosis, close observation, and treatment when radiographic findings or clinical symptoms become burdensome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur. 2013;16(2):66–9.
Zacharia B, Subramaniam D, Joy J. Skeletal Metastasis-an Epidemiological Study. Indian J Surg Oncol. 2018;9(1):46–51.
Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL, et al. Surgical management of metastatic spinal tumors. Cancer Control. 2012;19(2):122–8.
Choi D, Crockard A, Bunger C, Harms J, Kawahara N, Mazel C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215–22.
Sohn S, Chung CK, Han KD. Jung JH. Kim J, et al. A Nationwide Study of Surgery in a Newly Diagnosed Spine Metastasis Population. J Korean Neurosurg Soc: Hyeun JH; 2018.
Robial N, Charles YP, Bogorin I, Godet J, Beaujeux R, Boujan F, et al. Is preoperative embolization a prerequisite for spinal metastases surgical management? Orthop Traumatol Surg Res. 2012;98(5):536–42.
Smit JW, Vielvoye GJ, Goslings BM. Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab. 2000;85(3):989–94.
Suzuki H, Kondo T, Kuwatsuru R, Wada K, Kubota M, Kobayashi H, et al. Decompressive surgery in combination with preoperative transcatheter arterial embolization: successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression. Int J Urol. 2011;18(10):718–22.
Wilson MA, Cooke DL, Ghodke B, Mirza SK. Retrospective analysis of preoperative embolization of spinal tumors. AJNR Am J Neuroradiol. 2010;31(4):656–60.
Awad AW, Almefty KK, Ducruet AF, Turner JD, Theodore N, McDougall CG, et al. The efficacy and risks of preoperative embolization of spinal tumors. J Neurointerv Surg. 2016;8(8):859–64.
Patsalides A, Leng LZ, Kimball D, Marcus J, Knopman J, Laufer I, et al. Preoperative catheter spinal angiography and embolization of cervical spinal tumors: outcomes from a single center. Interv Neuroradiol. 2016;22(4):457–65.
Lasocki A, Gaillard F, Harrison SJ. Multiple myeloma of the spine. Neuroradiol J. 2017;30(3):259–68.
Latif T, Hussein MA. Advances in multiple myeloma and spine disease. Clin Lymphoma Myeloma. 2005;6(3):228–33.
Kim SI, Kim YH, Ha KY, Lee JW, Lee JW. Surgical roles for spinal involvement of hematological malignancies. J Korean Neurosurg Soc. 2017;60(5):534–9.
Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol. 2006;24(21):3388–93.
Barzilai O, Fisher CG, Bilsky MH. State of the art treatment of spinal metastatic disease. Neurosurgery. 2018;82(6):757–69.
Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005;80(9):1177–86.
Dunning EC, Butler JS, Morris S. Complications in the management of metastatic spinal disease. World J Orthop. 2012;3(8):114–21.
Buhl R, Barth H, Hugo HH, Hutzelmann A, Mehdorn HM. Spinal drop metastases in recurrent glioblastoma multiforme. Acta Neurochir. 1998;140(10):1001–5.
Carlsen JG, Tietze A, Lassen YA, Rosendal F. Paraplegia due to drop metastases from anaplastic oligodendroglioma. Br J Neurosurg. 2012;26(1):94–5.
Chandra P, Purandare N, Shah S, Agrawal A, Rangarajan V. “Drop” metastases from an operated case of intracranial anaplastic ependymoma identified on fluoro-2-deoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med. 2017;32(1):68–70.
Domingues RC, Taveras JM, Reimer P, Rosen BR. Foramen magnum choroid plexus papilloma with drop metastases to the lumbar spine. AJNR Am J Neuroradiol. 1991;12(3):564–5.
Hayes LL, Jones RA, Palasis S, Aguilera D, Porter DA. Drop metastases to the pediatric spine revealed with diffusion-weighted MR imaging. Pediatr Radiol. 2012;42(8):1009–13.
Pande SB, Pavithran K. Drop metastases to the spinal cord from infratentorial glioblastoma multiforme in post-temozolomide era. J Cancer Res Ther. 2015;11(4):1039.
Raaijmakers C, Wilms G, Demaerel P, Baert AL. Pineal teratocarcinoma with drop metastases: MR features. Neuroradiology. 1992;34(3):227–9.
Solomou AG. Magnetic resonance imaging of pineal tumors and drop metastases: a review approach. Rare Tumors. 2017;9(3):6715.
Yeamans CL, Gutierrez-Quintana R, Haley A, Lamm CG. Magnetic resonance imaging and clinical findings associated with choroid plexus spinal cord “drop” metastases. J Am Anim Hosp Assoc. 2017;53(5):265–9.
Yu H, Yao TL, Spooner J, Stumph JR, Hester R, Konrad PE. Delayed occurrence of multiple spinal drop metastases from a posterior fossa choroid plexus papilloma. Case report. J Neurosurg Spine. 2006;4(6):494–6.
Chamberlain MC. Leptomeningeal metastases in the MRI era. Neurology. 2011;76(2):200; author reply −1.
Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753.
Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010;13(3):324–8.
Laufer I, Rubin DG, Lis E, Cox BW, Stubblefield MD, Yamada Y, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–51.
Moussazadeh N, Laufer I, Yamada Y, Bilsky MH. Separation surgery for spinal metastases: effect of spinal radiosurgery on surgical treatment goals. Cancer Control. 2014;21(2):168–74.
Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010;35(22):E1221–9.
Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, et al. Reliability of the spinal instability neoplastic score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol. 2014;9:69.
Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011;29(22):3072–7.
Versteeg AL, Verlaan JJ, Sahgal A, Mendel E, Quraishi NA, Fourney DR, et al. The spinal instability neoplastic score: impact on oncologic decision-making. Spine (Phila Pa 1976). 2016;41:S231–S237.
Huisman M, van der Velden JM, van Vulpen M, van den Bosch MA, Chow E, Oner FC, et al. Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J. 2014;14(12):2835–40.
Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011;12(3):225–35.
Hussain I, Barzilai O, Reiner AS, DiStefano N, McLaughlin L, Ogilvie S, et al. Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery. Spine J. 2017;17:S181.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hussain, I., Pennicooke, B.H., Baaj, A.A. (2020). Introduction to Spinal Metastases. In: Ramakrishna, R., Magge, R., Baaj, A., Knisely, J. (eds) Central Nervous System Metastases. Springer, Cham. https://doi.org/10.1007/978-3-030-42958-4_34
Download citation
DOI: https://doi.org/10.1007/978-3-030-42958-4_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42957-7
Online ISBN: 978-3-030-42958-4
eBook Packages: MedicineMedicine (R0)